Meet Leon
Nano Science Excellence, Exemplified
We deliver novel, ready to use, validated, nano solutions that create value. Our team of experts work in collaboration with our clients and partners to deliver enhanced bioavailability, increased solubility and improved stability.
Find out moreAbout Leon
Enabling you to exploit the value of enhanced bioavailability, increased solubility and improved stability.It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon’s ‘enabling nano now’ value proposition delivers novel, ready to use, validated, nano solutions that create value for partners and meets an unmet medical need for patients.
Find out moreNews & Events
5 May 2020
leon-nanodrugs GmbH announces Dr Pascale Clement new Chief Technology Officer
The appointment strengthens scientific excellence and growth strategy leon-nanodrugs GmbH (“leon”), the Munich based nanotechnology drug development company, has recruited Dr Pascale Clement as its new Chief Technology Officer (CTO). Dr Clement joins leon from
28 April 2020
Andrea Cusack appointed Chief Executive Officer
Industry stalwart leads the nanotechnology pioneer to accelerate growth strategy. leon-nanodrugs GmbH (“leon”), the Munich based nanotechnology drug development company, has announced Andrea Cusack as its new Chief Executive Officer (CEO) and Managing Director. Cusack
16 April 2020
leon secures Series B funding to accelerate growth in enabling nano now, while establishing strategic partnership with Evotec
leon-nanodrugs GmbH, the leading enabler of nano technology for the pharmaceutical industry, announced today that it has successfully completed a Series B funding round. The capital will be used to further strengthen the company’s leadership